Your browser is no longer supported. Please, upgrade your browser.
Settings
ANIK Anika Therapeutics, Inc. daily Stock Chart
ANIK [NASD]
Anika Therapeutics, Inc.
Index- P/E34.91 EPS (ttm)1.13 Insider Own0.50% Shs Outstand14.26M Perf Week3.48%
Market Cap563.56M Forward P/E25.53 EPS next Y1.55 Insider Trans0.00% Shs Float13.68M Perf Month14.58%
Income16.80M PEG3.49 EPS next Q0.33 Inst Own93.20% Short Float17.53% Perf Quarter10.33%
Sales108.00M P/S5.22 EPS this Y-9.00% Inst Trans0.11% Short Ratio19.32 Perf Half Y-4.84%
Book/sh17.93 P/B2.20 EPS next Y43.73% ROA6.90% Target Price50.25 Perf Year-31.93%
Cash/sh10.45 P/C3.78 EPS next 5Y10.00% ROE7.40% 52W Range28.54 - 61.46 Perf YTD17.58%
Dividend- P/FCF22.63 EPS past 5Y19.00% ROI11.00% 52W High-35.69% Beta1.49
Dividend %- Quick Ratio18.50 Sales past 5Y9.70% Gross Margin69.40% 52W Low38.47% ATR1.03
Employees123 Current Ratio21.00 Sales Q/Q-1.50% Oper. Margin20.10% RSI (14)76.14 Volatility1.94% 2.81%
OptionableYes Debt/Eq0.00 EPS Q/Q16.00% Profit Margin17.70% Rel Volume0.69 Prev Close39.07
ShortableYes LT Debt/Eq0.00 EarningsFeb 21 AMC Payout0.00% Avg Volume124.11K Price39.52
Recom- SMA205.37% SMA5014.43% SMA2004.49% Volume85,581 Change1.15%
Jul-27-18Upgrade Barrington Research Mkt Perform → Outperform $48
Jun-20-18Downgrade First Analysis Sec Overweight → Equal-Weight $45 → $34
Jun-20-18Downgrade Barrington Research Outperform → Mkt Perform
May-04-18Upgrade Barrington Research Mkt Perform → Outperform $39
Feb-23-18Downgrade Barrington Research Outperform → Mkt Perform
Jan-24-18Upgrade First Analysis Sec Equal-Weight → Overweight $45 → $68
Oct-27-17Reiterated Barrington Research Outperform $53 → $57
May-09-16Upgrade Singular Research BUY - Long-Term → Buy $60
Apr-27-16Downgrade Northland Capital Outperform → Market Perform
Feb-26-16Reiterated Barrington Research Outperform $45 → $49
Oct-12-15Initiated Barrington Research Outperform $39
Aug-28-15Initiated First Analysis Sec Equal-Weight
Jul-30-15Reiterated Northland Capital Outperform $56 → $57
May-14-15Initiated Northland Capital Outperform $56
Nov-12-14Reiterated Singular Research BUY - Long-Term $51.50 → $45.50
Aug-19-14Downgrade Singular Research Buy → BUY - Long-Term $54 → $51.50
May-28-14Reiterated Singular Research Buy $43.50 → $54
Apr-08-14Reiterated Singular Research Buy $35 → $43.50
Feb-26-14Reiterated Summer Street Research Buy $47 → $60
Aug-02-13Reiterated Summer Street Research Buy $20 → $28
Feb-14-19 10:31AM  Analysts Estimate Anika Therapeutics (ANIK) to Report a Decline in Earnings: What to Look Out for Zacks
Feb-07-19 04:05PM  Anika to Issue Fourth-Quarter and Full-Year 2018 Financial Results and Business Highlights on Thursday, February 21 Business Wire
Feb-01-19 07:35AM  New Research: Key Drivers of Growth for Cisco, Landstar System, Central Garden & Pet, Anika Therapeutics, Hibbett Sports, and MoneyGram International Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jan-21-19 11:58AM  When Should You Buy Anika Therapeutics, Inc. (NASDAQ:ANIK)? Simply Wall St.
Jan-16-19 04:05PM  Anika Announces Plans to Showcase HYALOFAST at the International Cartilage Regeneration and Joint Preservation Society (ICRS) Summit in San Diego Business Wire
Jan-14-19 09:30AM  ANIK or TECH: Which Is the Better Value Stock Right Now? Zacks
Dec-27-18 03:13PM  6 Undervalued Stocks With Positive Earnings Growth Estimates GuruFocus.com
Dec-24-18 09:26AM  Alexion's Ultomiris Gets Early FDA Nod for Rare Blood Disorder Zacks
Dec-23-18 12:00PM  Hedge Funds Are Dumping Anika Therapeutics, Inc. (ANIK) Insider Monkey
Dec-21-18 09:19AM  Agenus' Stock Up 23% on Immuno-Oncology Deal With Gilead Zacks
Dec-20-18 12:39PM  Do You Know What Anika Therapeutics, Inc.s (NASDAQ:ANIK) P/E Ratio Means? Simply Wall St.
Dec-17-18 09:30AM  ANIK vs. RGEN: Which Stock Should Value Investors Buy Now? Zacks +5.62%
Dec-14-18 07:59AM  5 Biotech Stocks Set to Bounce Back in '19 After a Rough Ride Zacks
07:57AM  Anika Therapeutics Enters Oversold Territory Zacks
Dec-12-18 08:00AM  Anika to Showcase HYALOFAST at the International Cartilage Regeneration and Joint Preservation Society (ICRS) Focus Meeting in Milan Business Wire
Dec-10-18 08:44AM  Why Abeona Therapeutics (ABEO) Could Be Positioned for a Slump Zacks
Dec-04-18 04:05PM  Anika Resumes Global Distribution of HYALOFAST, HYALOGRAFT-C and HYALOMATRIX Business Wire -6.06%
Nov-13-18 02:43PM  Is Anika Therapeutics Incs (NASDAQ:ANIK) ROE Of 7.5% Concerning? Simply Wall St.
Nov-02-18 08:55AM  New Research: Key Drivers of Growth for Edison International, NuVasive, LogMein, Anika Therapeutics, First Industrial Realty Trust, and ON Semiconductor Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Oct-29-18 09:30AM  ANIK vs. RGNX: Which Stock Should Value Investors Buy Now? Zacks
Oct-25-18 10:16AM  Edited Transcript of ANIK earnings conference call or presentation 24-Oct-18 9:00pm GMT Thomson Reuters StreetEvents -8.76%
08:03AM  The Daily Biotech Pulse: AbbVie Takes Full Control Of Cystic Fibrosis Program, Amgen Slashes Cholesterol Drug Price Benzinga
Oct-24-18 08:02PM  Anika Therapeutics Inc (ANIK) Q3 2018 Earnings Conference Call Transcript Motley Fool
05:25PM  Anika Therapeutics (ANIK) Q3 Earnings Beat Estimates Zacks
04:17PM  Anika: 3Q Earnings Snapshot Associated Press
04:05PM  Anika Reports Third Quarter 2018 Financial Results Business Wire
08:30AM  Susan Vogt Appointed to Board of Directors of Anika Therapeutics Business Wire
Oct-22-18 11:22AM  What's in Store for Anika Therapeutics (ANIK) in Q3 Earnings? Zacks
Oct-17-18 10:32AM  Anika Therapeutics (ANIK) Q3 Earnings Preview: What to Look Out For Zacks
Oct-11-18 08:15AM  Market Trends Toward New Normal in Park Hotels & Resorts, Safety Insurance Group, Cincinnati Financial, Anika Therapeutics, CME Group, and Midstates Petroleum Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Oct-10-18 04:05PM  Anika to Issue Third-Quarter 2018 Financial Results and Business Highlights on Wednesday, October 24 Business Wire
Sep-28-18 10:58AM  Ultragenyx Reports Top-line Data From Gene Therapy Candidate Zacks
Sep-27-18 08:49AM  AVEO Pharmaceuticals (AVEO) Soars: Stock Adds 6.4% in Session Zacks
Sep-26-18 08:59AM  Novavax (NVAX) Catches Eye: Stock Jumps 7.6% Zacks
Sep-25-18 11:18AM  Arena (ARNA) Posts Favorable Top-Line Data on Pain Candidate Zacks
10:52AM  FDA Lifts Clinical Hold on Epizyme's Lead Candidate's Study Zacks
10:44AM  FDA Lifts Clinical Hold on Sarepta's DMD Gene Therapy Program Zacks
08:50AM  Alexion Pharmaceuticals (ALXN) Surges: Stock Moves 5.3% Higher Zacks
Sep-05-18 04:05PM  Anika to Participate in the 2018 Morgan Stanley Global Healthcare Conference on September 12, 2018 Business Wire
04:05PM  Anika Appoints Dr. Cheryl Blanchard to Its Board of Directors Business Wire
Sep-04-18 09:28AM  How Financially Strong Is Anika Therapeutics Inc (NASDAQ:ANIK)? Simply Wall St.
Aug-07-18 09:30AM  ANIK vs. ALKS: Which Stock Is the Better Value Option? Zacks
07:50AM  Analysis: Positioning to Benefit within Anika Therapeutics, Ameris, Century Communities, Energous, Consolidated Communications, and Globalstar Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Aug-01-18 09:29PM  Edited Transcript of ANIK earnings conference call or presentation 26-Jul-18 1:00pm GMT Thomson Reuters StreetEvents
Jul-31-18 07:15AM  Blog Exposure - CHMP Adopts Positive Opinion for Alnylams Patisiran for HATTR Amyloidosis Treatment ACCESSWIRE
Jul-26-18 05:03AM  Anika: 2Q Earnings Snapshot Associated Press +19.72%
Jul-25-18 04:05PM  Anika Reports Second Quarter 2018 Financial Results Business Wire
09:52AM  Anika Therapeutics Q2 Earnings Outlook Benzinga
Jul-11-18 04:05PM  Anika to Issue Second-Quarter 2018 Financial Results and Business Highlights on Wednesday, July 25 Business Wire
Jun-22-18 01:04PM  2 Biotech Stocks That Tanked This Week: Can They Recover? Motley Fool
Jun-21-18 04:14PM  Anika Reports Top Line Data from CINGAL Study, Shares Slump Zacks
08:39AM  Benzinga's Daily Biotech Pulse: AbbVie Launches New Pediatric Humira, IPO Deluge Hits The Street Benzinga
08:15AM  Today's Research Reports on Stocks to Watch: Anika Therapeutics and Tesaro ACCESSWIRE
Jun-20-18 04:46PM  Why Pivotal Software, Anika Therapeutics, and Oracle Slumped Today Motley Fool -37.62%
11:41AM  Why Anika Therapeutics, Inc. Stock Is Sinking Motley Fool
08:36AM  Benzinga's Daily Biotech Pulse: Sarepta's DMD Gene Therapy, Anika's Flunked Trial, Eidos To Commence Trading Benzinga
08:32AM  Biotech Stock Roundup: SRPT & SLDB Soar on Positive Data, ANIK & ZIOP Crash Zacks
Jun-19-18 04:05PM  Anika Therapeutics Announces Top-Line Results from CINGAL 16-02 Clinical Trial in Knee Osteoarthritis Business Wire
May-23-18 04:05PM  Anika Therapeutics Announces $30 Million Accelerated Share Repurchase Business Wire
May-18-18 08:44AM  Weakness Seen in Anika Therapeutics (ANIK) Estimates: Should You Stay Away? Zacks
May-16-18 03:52PM  Edited Transcript of ANIK earnings conference call or presentation 3-May-18 1:00pm GMT Thomson Reuters StreetEvents
May-08-18 04:05PM  Anika to Showcase Commercial and Pipeline Portfolio at 18th Bi-Annual European Society for Sports Traumatology, Knee Surgery and Arthroscopy Congress Business Wire
May-02-18 06:19PM  Anika: 1Q Earnings Snapshot Associated Press
04:05PM  Anika Reports First Quarter 2018 Financial Results Business Wire
11:46AM  How Did Anika Therapeutics Incs (NASDAQ:ANIK) 12.08% ROE Fare Against The Industry? Simply Wall St.
May-01-18 07:55AM  Report: Developing Opportunities within AMC Networks, JELD-WEN Holding, Blueprint Medicines, Northwest Bancshares, Anika Therapeutics, and Aethlon Medical Future Expectations, Projections Moving into 2018 GlobeNewswire
Apr-24-18 04:05PM  Anika to Present at the 2018 Deutsche Bank Health Care Conference on May 8, 2018 Business Wire
Apr-18-18 04:13PM  Anika to Issue First-Quarter 2018 Financial Results and Business Highlights on Wednesday, May 2 Business Wire
Apr-16-18 07:33AM  New Strong Sell Stocks for April 16th Zacks
Apr-06-18 08:00AM  Anika Announces Plans to Showcase HYALOFAST Hyaluronic Acid-Based Scaffold at the 2018 World Congress of the International Cartilage Repair Society Business Wire
07:59AM  New Strong Sell Stocks for April 6th Zacks
Apr-02-18 04:33AM  New Strong Sell Stocks for April 2nd Zacks
Mar-29-18 08:15AM  With A -2.25% Earnings Drop, Is Anika Therapeutics Incs (FRA:AKP) A Concern? Simply Wall St.
Mar-22-18 01:21PM  Edited Transcript of ANIK earnings conference call or presentation 22-Feb-18 2:00pm GMT Thomson Reuters StreetEvents
08:20AM  Recent Analysis Shows PTC, 1st Source, Westar Energy, Anika Therapeutics, Stock Yards, and Central Garden & Pet Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Mar-06-18 07:00AM  Anika to Showcase Commercial and Pipeline Portfolio at 2018 AAOS Annual Meeting GlobeNewswire
Mar-05-18 04:02PM  Joseph Darling Named CEO and Director of Anika Therapeutics GlobeNewswire
Feb-27-18 07:48AM  Anika Therapeutics Inc (ANIK) Files 10-K for the Fiscal Year Ended on December 31, 2017 GuruFocus.com
07:17AM  New Strong Sell Stocks for February 27th Zacks
07:00AM  Wired News - Jazz Pharma Enrolled First Patient in Phase-2 Clinical Trial Assessing Defibrotide for the Prevention of Acute Graft-versus-Host Disease ACCESSWIRE
Feb-23-18 10:11AM  Anika Therapeutics Shares Stunted By Increased Investment, Barrington Says In Downgrade Benzinga -10.43%
Feb-22-18 07:40AM  Anika Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
Feb-21-18 05:41PM  Anika posts 4Q profit Associated Press
04:05PM  Anika Reports Fourth Quarter and Full Year 2017 Financial Results Business Wire
12:08PM  When Should You Buy Anika Therapeutics Inc (NASDAQ:ANIK)? Simply Wall St.
Feb-07-18 04:05PM  Anika to Issue Fourth-Quarter 2017 Financial Results and Business Highlights on Wednesday, February 21 Business Wire
Feb-01-18 04:05PM  Anika Therapeutics Announces Strategic Collaboration with the Institute of Integrative Biology at the University of Liverpool to Develop an Innovative Therapy for Osteoarthritis Business Wire
Jan-24-18 04:05PM  Anika Therapeutics Expands Strategic Collaboration with the Institute for Applied Life Sciences (IALS) at the University of Massachusetts Amherst to Develop Innovative Therapy for Rheumatoid Arthritis Business Wire
Jan-22-18 08:20AM  Recent Analysis Shows Darling Ingredients, Principal Financial Group, UGI, Cass Information, WD-40, and Anika Therapeutics Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Jan-03-18 03:04AM  Anika Therapeutics Receives FDA Nod for Bone Repair Therapy Zacks
Dec-28-17 11:38AM  Analyst: Don't Expect Anika's Latest FDA Cleared Treatment To Impact 2018 Benzinga
Dec-27-17 08:05AM  Anika Announces FDA 510(k) Clearance for Its Injectable HA-Based Bone Repair Treatment Business Wire
Dec-25-17 11:41AM  ETFs with exposure to Anika Therapeutics, Inc. : December 25, 2017 Capital Cube
Dec-14-17 03:21PM  7 Quality Stocks With High Business Predictability Ratings GuruFocus.com
Dec-13-17 12:42PM  ETFs with exposure to Anika Therapeutics, Inc. : December 13, 2017 Capital Cube
Nov-27-17 12:00PM  ETFs with exposure to Anika Therapeutics, Inc. : November 27, 2017 Capital Cube
Nov-14-17 01:54PM  ETFs with exposure to Anika Therapeutics, Inc. : November 14, 2017 Capital Cube
Nov-02-17 11:44AM  ETFs with exposure to Anika Therapeutics, Inc. : November 2, 2017 Capital Cube
Nov-01-17 09:31AM  Anika Therapeutics, Inc. :ANIK-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017 Capital Cube
Oct-30-17 12:34PM  Anika Therapeutics, Inc. Value Analysis (NASDAQ:ANIK) : October 30, 2017 Capital Cube
Anika Therapeutics, Inc., together with its subsidiaries, provides orthopedic medicines for patients with degenerative orthopedic diseases and traumatic conditions in the United States and internationally. The company develops, manufactures, and commercializes therapeutic products based on its proprietary hyaluronic acid (HA) technology. Its orthobiologics products comprise ORTHOVISC, ORTHOVISC mini, MONOVISC, and CINGAL for the treatment of osteoarthritis of the knee; HYALOFAST, a biodegradable support for human bone marrow mesenchymal stem cells used for cartilage regeneration and as an adjunct for microfracture surgery; HYALONECT, a resorbable knitted fabric mesh; HYALOSS used to mix blood/bone grafts to form a paste for bone regeneration; and HYALOGLIDE, an ACP gel used in tenolysis treatment. The company's dermal products include wound care products that comprise HYALOMATRIX and HYALOFILL for the treatment of complex wounds, such as burns and ulcers, and for use in connection with the regeneration of skin; and ELEVESS, an aesthetic dermatology product. Its surgical products comprise HYALOBARRIER, a post-operative adhesion barrier for use in the abdomino-pelvic area; INCERT, a HA product used for the prevention of post-surgical spinal adhesions; MEROGEL, a woven fleece nasal packing; and MEROGEL INJECTABLE, a viscous hydrogel. The company also offers ophthalmic products, including injectable HA products that are used as viscoelastic agents in ophthalmic surgical procedures, such as cataract extraction and intraocular lens implantation; and veterinary products, which include HYVISC, an injectable HA product for the treatment of joint dysfunction in horses. Anika Therapeutics, Inc. has a strategic collaboration with the Institute for Applied Life Sciences at the University of Massachusetts Amherst to develop a therapy for rheumatoid arthritis. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.